Ascentage Pharma Group International’s (NASDAQ:AAPG) Quiet Period To End on March 5th

Ascentage Pharma Group International’s (NASDAQ:AAPG) quiet period will end on Wednesday, March 5th. Ascentage Pharma Group International had issued 7,325,000 shares in its initial public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. During Ascentage Pharma Group International’s quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Ascentage Pharma Group International Stock Down 4.5 %

Shares of Ascentage Pharma Group International stock traded down $0.89 on Friday, reaching $18.91. 16,172 shares of the stock were exchanged, compared to its average volume of 135,278. Ascentage Pharma Group International has a one year low of $16.50 and a one year high of $21.40.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.